Does the type of disease-modifying drugs impact on the quality of life in patients with relapsing-remitting multiple sclerosis?

Unknown, Amirreza Naseri, Unknown, Ehsan Nasiri, Unknown, Unknown, Malihe Talebi, Unknown, Kimia Karimi, Unknown, Mahnaz Talebi, Unknown

Open source

DOI: 10.37897/rjn.2020.3.6
Published: 2020-09-30
Container: Romanian Journal of Neurology
Publisher: AMALTEA Medical Publishing House
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.37897/rjn.2020.3.6,
  title = {Does the type of disease-modifying drugs impact on the quality of life in patients with relapsing-remitting multiple sclerosis?},
  author = {Unknown and Amirreza Naseri and Unknown and Ehsan Nasiri and Unknown and Unknown and Malihe Talebi and Unknown and Kimia Karimi and Unknown and Mahnaz Talebi and Unknown},
  year = {2020},
  journal = {Romanian Journal of Neurology},
  doi = {10.37897/rjn.2020.3.6},
  url = {https://doi.org/10.37897/rjn.2020.3.6}
}

RIS

TY  - JOUR
TI  - Does the type of disease-modifying drugs impact on the quality of life in patients with relapsing-remitting multiple sclerosis?
AU  - Unknown
AU  - Amirreza Naseri
AU  - Unknown
AU  - Ehsan Nasiri
AU  - Unknown
AU  - Unknown
AU  - Malihe Talebi
AU  - Unknown
AU  - Kimia Karimi
AU  - Unknown
AU  - Mahnaz Talebi
AU  - Unknown
PY  - 2020
JO  - Romanian Journal of Neurology
DO  - 10.37897/rjn.2020.3.6
UR  - https://doi.org/10.37897/rjn.2020.3.6
ER  -

APA

Unknown, Naseri, A., Unknown, Nasiri, E., Unknown, Unknown, Talebi, M., Unknown, Karimi, K., Unknown, Talebi, M., & Unknown (2020). Does the type of disease-modifying drugs impact on the quality of life in patients with relapsing-remitting multiple sclerosis?. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2020.3.6

Source records

crossref · retrieved 2026-09-25T01:21:12.595Z